Clinical AI's Accuracy Question Was Never the Whole Question
FDA's own framework gaps show interaction risk matters as much as accuracy, but the on-premise architecture fix now circulating is a contested proposal, not a settled control.
FDA's own framework gaps show interaction risk matters as much as accuracy, but the on-premise architecture fix now circulating is a contested proposal, not a settled control.